Q3 2025 Management View CEO John Forsyth highlighted Q3 FY25 revenue of $555.7 million, which exceeded the top end of the guidance range, driven by stronger-than-expected demand for smartphone ...
Gland Pharma's consolidated net profit increased 6.67% to Rs 204.70 crore despite 10.42% decline in revenue from operations to Rs 1,384.1 crore in Q3 FY25 over Q3 FY25.